ArticleEuropean heart journal. Digital health2026
Feasibility and performance evaluation of PPG on a Galaxy Watch in continuous central blood pressure monitoring.
Article in European heart journal. Digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Wearable, cuffless blood pressure (BP) monitoring systems using photoplethysmography (PPG) offer promising alternatives to traditional methods for out-of-office BP but lack rigorous validation against invasive continuous central BP measurement. This study aimed to develop and evaluate a smartwatch-based algorithm for detecting changes in mean arterial pressure (MAP) using PPG signals from the Samsung Galaxy Watch, with invasive central BP as the reference standard. Methods and results: A novel algorithm was developed and calibrated using 6117 measurements from 440 participants. External evaluation was performed prospectively in 114 participants undergoing left and/or right heart catheterization, where central aortic BP was recorded at 1-min intervals using pigtail catheters. Simultaneous non-invasive PPG signals were collected from Galaxy Watch 6. The primary endpoint was the detection of a ≥15% increase in MAP from baseline, with receiver operating characteristic analysis performed to evaluate diagnostic accuracy. After calibration, the smartwatch-estimated MAP changes demonstrated strong correlation with invasive measurements ( Conclusion: This study demonstrates the preliminary feasibility and accuracy of a PPG-based smartwatch algorithm for detecting meaningful BP changes in real time without the need for frequent calibration. Since our protocol did not meet the relevant validation requirements, further studies are needed to substantiate its potential clinical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.